Role Of CXCR3and Its Ligand I-TAC In The Pathogenesis Of Immune Thrombocytopenic Purpura | | Posted on:2013-02-01 | Degree:Master | Type:Thesis | | Country:China | Candidate:X Zhang | Full Text:PDF | | GTID:2234330362467063 | Subject:Internal Medicine | | Abstract/Summary: | PDF Full Text Request | | Objective To investigate the roles and significance of the chemokine receptorCXCR3and its ligand I-TAC in the pathogenesis of immune thrombocytopenicpurpura (ITP) and to make clear their levels after immunosuppresive therapy.Methods A total of48ITP patients were enrolled in this study:30with newlydiagnosed or relapse ITP and18in remission after treatment, as well as24healthyvolunteers as controls. Gamma interferon (IFN-γ) and I-TAC in the plasma weredetected by enzyme-linked immunosorbent assay (ELISA). The mRNA expression ofCXCR3in the peripheral blood mononuclear cell (PBMNC) was determined byquantitative real-time polymerase chain reaction (RT-PCR).Results The IFN-γ level in the plasma of ITP patients before the treatment(71.45±17.62pg/ml) were obviously increased than those in the remission group(36.9±14.9pg/ml)and the normal controls(25.28±12.85pg/ml)(all P<0.05), andthose in remission group was higher than those in the controls (P<0.05). In contrast,the levels of I-TAC, there were no statistic difference among patients before thetreatment of ITP(455.56±144.700pg/ml) and remission group(488.24±164.70pg/ml) and the healthy controls(382.97±167.43pg/ml)(P>0.05). Both ITP patientsbefore the treatment(M6.76)(3.03,37.00)and remission groups(M1.76)(0.45,14.18)expressed more CXCR3mRNA (P<0.05). After effective therapy, CXCR3mRNA expression decreased, while it was still higher than those in the controls(M0.12)(0.04,0.28)(P<0.05).Conclusions Our data demonstrated that Th1cytokine (IFN-γ) dominance wasreflected in ITP. Simultaneously, the CXCR3~+cell may play a role in cell-mediatedimmunity through chemotaxis in ITP. In addition to above, this axis is influenced byimmunosuppresive therapy. | | Keywords/Search Tags: | Purpura, thrombocytopenic, idiopathic, Interferon type Ⅱ, CXCR3, I-TAC | PDF Full Text Request | Related items |
| |
|